CNS Pharmaceuticals Inc.
(CNSP)
undefined
undefined%
At close: undefined
0.10
2.31%
Pre-market Dec 16, 2024, 05:50 AM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -0.06 | -53.49 | -308.92 | -776.34 | -4189.45 | -2542.38 | -35696.28 |
PS Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio | -0.27 | 100.46 | 676.22 | 526.42 | 2136.99 | -34212.73 | -321071.94 |
P/FCF Ratio | -0.08 | -77.36 | -330.61 | -1000.89 | -4545.40 | -26233.08 | -167499.87 |
P/OCF Ratio | -0.08 | -77.39 | -330.75 | -1003.35 | -4571.13 | -26233.08 | -167499.87 |
OCF/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / Equity Ratio | -0.02 | 0.01 | 0.01 | 0.01 | 0.00 | -0.14 | -0.52 |
Quick Ratio | 0.06 | 0.64 | 0.88 | 2.03 | 6.35 | 0.12 | 0.18 |
Current Ratio | 0.06 | 0.64 | 0.88 | 2.03 | 6.35 | 0.12 | 0.18 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | 0.00 | -543.16 | -377.69 | -724.16 | -21.66 | -4.72 | 0.00 |
Return on Equity (ROE) | 425.33% | -187.81% | -218.90% | -67.81% | -51.01% | 1345.70% | 899.45% |
Return on Assets (ROA) | -1108.34% | -117.02% | -165.52% | -59.66% | -49.00% | -1081.74% | -324.59% |
Return on Capital (ROIC) | 425.65% | -187.72% | -211.83% | -67.78% | -50.43% | 160.53% | 367.49% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |